Literature DB >> 18776892

Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory.

François V Bolduc1, Kimberly Bell, Hilary Cox, Kendal S Broadie, Tim Tully.   

Abstract

We used Drosophila olfactory memory as a model to study the molecular basis of cognitive defects in Fragile X syndrome in vivo. We observed that fragile X protein was acutely required and interacted with argonaute1 and staufen in the formation of long-term memory. Occlusion of long-term memory formation in Fragile X mutants could be rescued by protein synthesis inhibitors, suggesting that excess baseline protein synthesis could negatively affect cognition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776892      PMCID: PMC3038669          DOI: 10.1038/nn.2175

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


INTRODUCTION

Fragile X mental retardation syndrome, caused by the absence of FMRP, is the most frequent cause of heritable mental retardation in males. Lack of FMRP has been associated with increases in general protein synthesis 1 downstream of metabotropic glutamate receptor (mGluR) activation 2. FMRP is associated with elements of LTM such as protein synthesis, staufen 3, 4 and the RNAi pathway 5, 6 but the link between excess protein synthesis and cognition remains unclear.

RESULTS

Fmr1 is involved in olfactory learning and long-term memory formation

We took advantage of two null alleles of Fmr1, Fmr1 and Fmr1 to investigate memory formation after Pavlovian olfactory conditioning 7 in Drosophila . We confirmed that FMRP is not detected in brains of these Fmr1 mutants (Fig. S1a,b). Nonetheless, these mutants respond normally to the odors and footshock (Fig. S1c,d). After repetitive training sessions, two distinct forms of long-lasting memory can be distinguished 7. Massed training (MT) (ten training sessions without rest interval) produces a decremental, cycloheximide-insensitive memory (ARM), while spaced training (ST) (ten training sessions with a 15-min rest interval) produces both ARM and a nondecremental cycloheximide-sensitive (protein synthesis-dependent) long-term memory (LTM). Mutants homozygous for either the Fmr1 or Fmr1 allele showed defects in one-day memory after ST but not after MT, and this LTM defect is rescued in Fmr1 mutants expressing a genomic transgene containing Fmr1+ driven by its endogenous promoter (Fig. 1 a,b). Mutants heteroallelic for Fmr1 and Fmr1 were also defective for one-day memory after ST but not after MT. (Fig. 1 c,d).
Figure 1

Drosophila FMRP is required for olfactory learning and 1-day memory after ST

A) One-day memory after ST is defective in (vs. WT, P < 0.0001) and (vs. WT, P < 0.0001) and rescued with (vs. Fmr1, P < 0.0001; vs. WT, P = 0.715). B) In contrast, one-day memory after MT was normal. N = 8 PIs per group. C) Defective one-day memory after ST in (vs. WT, P = 0.0001), D) but normal after MT. N = 8 PIs per group. E) One-day memory after ST was significantly lower than in (vs. WT, P < 0.0001), (vs. WT, P = 0.001), (vs. WT, P = 0.0046) and in (vs. WT, P = 0.001) flies, but normal in the control genotypes: , , and . N = 8, 8, 4, 8, 8, 8, 8 and 8 PIs. F) One-day memory after MT for any of the groups in E) was normal. N = 4–8 PIs for each genotype. G) Learning was significantly lower than in (vs. WT, P = 0.0062), (vs. WT, P = 0.0002), (vs. WT, P = 0.0045) or (vs. WT, P = 0.034). N = 4 PIs per group. All graphs depict mean +/− S.E.M. H) elavGAL4/+;UAS-FmrRNAi (1-7)/+ present MB midline crossing defect (N=20).

We determined a spatial requirement for FMRP by evaluating LTM formation using RNA interference. Western blot analysis from adult brain after pan-neuronally restricted expression of the UAS-FmrRNAi construct with Elav-GAL4 revealed a significant decrease (40% of baseline) in FMRP level (Fig. S1g,h). Furthermore, we replicated the ß-lobe midline crossing defect (classified as in 8 : 4 severe, 3 moderate and 2 mild in 20 brains for transgenic flies, compared to 0 for each category in 20 brains from wild-type flies) (Fig. 1h). We then evaluated the effects on LTM formation of FMRP knockdowns restricted to the MB, because of its previously demonstrated role in olfactory LTM formation 9. Using two different MB PGAL4 drivers and two different UAS-FmrRNAi constructs, knockdown of FMRP yielded defects in one-day memory after ST but not after MT (Fig. 1 e,f). Interestingly, we observed decreased FMRP level in Kenyon cells (Fig. S2e) but no ß-lobe midline crossing when expression of UAS-Fmr-RNAi was restricted to the MB (using either OK107-Gal4 or 747-Gal4; N=20 flies per genotype; Fig. S2f). In contrast to these results, knockdown of FMRP in the central complex (Feb170) or projection neurons from antennal lobe (GH146) did not yield defects in one-day memory after ST (Fig. S1f). Considering the high prevalence of learning disability in Fragile X patients , defects in MBs of Fmr1 mutants 8 and their role in learning 10, we asked whether olfactory learning was impaired in Fmr1 mutants and observed significant defects in Fmr1, Fmr1 homozygotes, the Fmr1/Fmr1 heteroallelic mutant and in flies expressing UAS-FmrRNAi in MB (Fig. 1g).

FMRP is required physiologically in adult for LTM

To dissect the involvement of FMRP in brain development (see Fig. 1h) from its physiological role during adult LTM formation, we modulated FMRP expression using conditional transgenic tools. Acute adult heat shock-induced overexpression of wild-type FMRP produced a significant decrement in one-day memory after ST but not after MT (Fig. 2 a,c, d). In contrast, overexpression of FMRP after ST beyond memory consolidation (Fig. 2b) did not affect one-day memory (Fig. 2c). Interestingly, learning appeared normal at 3 or 24 hours after overexpression of Fmr1+ in adult (Fig. S2a).
Figure 2

Drosophila FMRP is required acutely for LTM formation and interacts with Staufen and Argonaute 1

A) Protocol used to overexpress UAS-Fmr+ before training or B) after training. C) One-day memory in flies heat-shocked (+) before ST (

We confirmed these results with complementary experiments using spatio-temporal control of RNAi-mediate knockdown of FMRP. We used the temperature-sensitive, tubulin-driven GAL80 transgene, along with MB (747) GAL4-driven expression of UAS-FmrRNAi to disrupt FMRP specifically in adult MB. At restrictive temperature (30°C), when GAL80ts no longer represses GAL4-driven expression of UAS-FmrRNAi, we observed a significant defect in one-day memory after ST but not after MT (Fig. 2e,f). Learning was normal (Fig. S2B). At permissive temperature (18°C), when GAL80ts is capable to inhibit GAL4-driven expression of UAS-FmrRNAi, one-day memory after spaced or massed training was normal (Fig. S2c,d). Despite a significantly decreased FMRP level in Kenyon cells after incubation at restrictive temperature (30C; Fig. S2g), no MB midline defect was observed (0/20 brains) (Fig. S2h). We observed a significant increase in FMRP expression acutely after ST (P<0.0001) but not after MT (P=0,123) (Fig. S3a,b). Interestingly, we observed that Drosophila adenylyl cyclase mutants, rutabaga, had lower FMRP level (Fig. S1e).

Staufen and Argonaute 1 interact with FMRP during memory formation

Staufen has been co-localized with FMRP in neural granules and has been implicated in LTM formation 4. Thus, we asked whether Fmr1 and stau interact functionally, using a classic test for genetic interaction. Heterozygous stau/+ or Fmr1/+ flies displayed normal one-day memory after spaced or massed training; in contrast, double heterozygous stau/+;Fmr1/+ flies showed defective one-day memory after ST but not after MT (Fig. 2g,h). This result suggests that FMRP and Staufen interact genetically during LTM formation specifically. FMRP also has been implicated as a molecular component of the RISC (RNAi) complex with Ago1. So we decided to evaluate whether Fmr1 and Ago1 interacted during memory formation. Heterozygous Fmr1/+ or Ago1/+ flies displayed normal one-day memory after spaced or massed training; in contrast, the double heterozygote, Ago1/+; Fmr1/+, showed defective one-day memory after ST but not after massed training (Fig. 2i, j). No such transdominant effect was observed in Ago2/+;Fmr1/+ flies (Fig. S3c). We also were able to demonstrate an acute adult effect of Ago1 overexpression on LTM formation (Fig. S3d). Together with the transdominant interaction between FMRP and Ago1, this observation suggests that FMRP regulates LTM formation via the miRNA pathway.

Inhibition of protein synthesis ameliorates the LTM defect in Fmr1 mutants

Several reports of increased global protein synthesis have led to the hypothesis that FMRP inhibits protein synthesis. So, could this FMRP-mediated misregulation of protein synthesis affect LTM formation? We tested this question by feeding wild-type and Fmr1 mutants flies protein synthesis inhibitors, cycloheximide (CXM) or puromycin (PURO). We used variations around concentration established for memory inhibition for CXM 7 and measurement of protein synthesis inhibition in Drosophila brain for Puromycin (Tully, unpublished). At relatively low concentrations of CXM or PURO, one-day memory after ST was not affected in wild-type flies but significantly ameliorated in the Fmr1 and Fmr1 mutants (Fig. 3a,c), while no effects on one-day memory after MT were observed (Fig. 3b,d). We also observed a significant improvement of LTM with metabotropic glutamate receptor antagonist, MPEP, for the Fmr1 and Fmr1 mutants (Fig. 3e; cf. 11).
Figure 3

Inhibition of protein synthesis ameliorates the LTM defect of Fmr1 mutants

A) At the low cycloheximide dose (8.75mM or 17.5mM), one day memory after ST in wild-type flies was not affected (P=0.682, P = 0.977). performance was not modified at 8.75mM (P=0.4229) but was ameliorated at 17.5mM (P = 0.0244), as was (P=0.0196). At the 35mM, performance in wild-type flies was reduced (P = 0.018), while was unaffected (P = 0.806). N = 8 PIs per group. B) One-day memory after MT was unaffected. N = 8 PIs per group. C) Puromycin at low dose (2.5mM and 5mM) had no effect in wild-type (P = 0.278, P = 0.133). No effect for with 2.5mM (P = 0.174) but 5mM Puromycin ameliorated performance of both (P = 0.0233) and (P = 0.0173), while puromycin 10mM disrupted memory in wild-type (P = 0.0059) but had no effect on (P = 0.979). N = 8 – 12 PIs per group. D) One-day memory after MT was unaffected by puromycin in wild-type or . N = 8 PIs per group. E) MPEP, ameliorated one-day memory after ST in Fmr1 mutants (Fmr1: P =0.0355; Fmr1: P =0.0024). N = 8 PIs per group. F) CXM (17.5mM) ameliorated the deficit in one-day memory after ST in (P=0.0452) and (P = 0.0058). N = 8 PIs per group. All graphs depict mean +/− S.E.M.

The genetic interaction of Fmr1 with staufen and Ago1 (above) led us to consider that excess protein synthesis may occur via a deregulation of the miRNA pathway in Fragile X mutants. To test this hypothesis, we assessed the effects of CXM on the Ago1/+;Fmr1/+ and Ago1/+;Fmr1/+ double heterozygotes. The memory defect one day after ST of the double heterozygote was significantly ameliorated in the drug-treated group compared to the vehicle-treated group (Fig. 3f). Together, these data reveal an ongoing requirement for FMRP, protein synthesis and miRNA processing during LTM formation.

DISCUSSION

Our behavioral study is the first to show an acute requirement for FMRP during long-term memory formation. Our results suggest that LTM dysfunction in Fmr1 mutants occurs via a miRNA-dependent misregulation of protein synthesis involving Ago1 and staufen. A general excess of protein synthesis possibly occludes the synthesis of subset of proteins required for LTM. This molecular mechanism may ramify more generally, as inhibition of protein synthesis reverses epileptic activity in the Fragile X knockout mouse 12. Our data also extend to the behavioral level the observation that dendritic elongation in response to the metabotropic glutamate receptor agonist, DHPG, could be blocked by the protein synthesis inhibitor, puromycin 13. In addition, the occlusion hypothesis could explain why the Fragile X knockout mouse failed to assemble polyribosomes and synthesize PSD95 and AMPAR in response to DHPG treatment 14, 15. More generally, the therapeutic use of inhibitors of protein synthesis may extend to other disorders, such as tuberous sclerosis, where deregulation of baseline protein synthesis also occurs or dampen other behavioral defects associated with Fragile X disease. Supplementary Figure 1 Neurogenetic characterizations of disruptions of Fmr1 Supplementary Figure 2 Characterization of the acute role of FMRP Supplementary Figure 3 FMRP is acutely involved in LTM formation
  15 in total

1.  The staufen/pumilio pathway is involved in Drosophila long-term memory.

Authors:  Josh Dubnau; Ann-Shyn Chiang; Lori Grady; Jody Barditch; Scott Gossweiler; John McNeil; Patrick Smith; Francois Buldoc; Rod Scott; Uli Certa; Clemens Broger; Tim Tully
Journal:  Curr Biol       Date:  2003-02-18       Impact factor: 10.834

2.  Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome.

Authors:  Sean M J McBride; Catherine H Choi; Yan Wang; David Liebelt; Evan Braunstein; David Ferreiro; Amita Sehgal; Kathleen K Siwicki; Thomas C Dockendorff; Hanh T Nguyen; Thomas V McDonald; Thomas A Jongens
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

3.  Associative odor learning in Drosophila abolished by chemical ablation of mushroom bodies.

Authors:  J S de Belle; M Heisenberg
Journal:  Science       Date:  1994-02-04       Impact factor: 47.728

4.  Genetic dissection of consolidated memory in Drosophila.

Authors:  T Tully; T Preat; S C Boynton; M Del Vecchio
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

5.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.

Authors:  Peng Jin; Daniela C Zarnescu; Stephanie Ceman; Mika Nakamoto; Julie Mowrey; Thomas A Jongens; David L Nelson; Kevin Moses; Stephen T Warren
Journal:  Nat Neurosci       Date:  2004-01-04       Impact factor: 24.884

Review 6.  The mGluR theory of fragile X mental retardation.

Authors:  Mark F Bear; Kimberly M Huber; Stephen T Warren
Journal:  Trends Neurosci       Date:  2004-07       Impact factor: 13.837

7.  Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants.

Authors:  Carlos I Michel; Robert Kraft; Linda L Restifo
Journal:  J Neurosci       Date:  2004-06-23       Impact factor: 6.167

8.  Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.

Authors:  Ravi S Muddashetty; Sofija Kelić; Christina Gross; Mei Xu; Gary J Bassell
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

9.  Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses.

Authors:  Ivan Jeanne Weiler; Chad C Spangler; Anna Y Klintsova; Aaron W Grossman; Soong Ho Kim; Valerie Bertaina-Anglade; Hooma Khaliq; Froukje E de Vries; Femke A E Lambers; Fatima Hatia; Christine K Base; William T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

10.  Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies.

Authors:  Scott A Barbee; Patricia S Estes; Anne-Marie Cziko; Jens Hillebrand; Rene A Luedeman; Jeff M Coller; Nick Johnson; Iris C Howlett; Cuiyun Geng; Ryu Ueda; Andrea H Brand; Sarah F Newbury; James E Wilhelm; Richard B Levine; Akira Nakamura; Roy Parker; Mani Ramaswami
Journal:  Neuron       Date:  2006-12-21       Impact factor: 17.173

View more
  125 in total

Review 1.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

Review 2.  Mechanisms of translational regulation in synaptic plasticity.

Authors:  Wayne S Sossin; Jean-Claude Lacaille
Journal:  Curr Opin Neurobiol       Date:  2010-04-27       Impact factor: 6.627

3.  Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Authors:  Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; Paul Hinchey; Maria Kollaros; Michael J Gertner; Newton H Woo; Michael R Tranfaglia; Mark F Bear; R Suzanne Zukin; Thomas V McDonald; Thomas A Jongens; Sean M J McBride
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

Review 4.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

5.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

Review 6.  Lithium: a promising treatment for fragile X syndrome.

Authors:  Zhonghua Liu; Carolyn Beebe Smith
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

Review 7.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

8.  ben Functions with scamp during synaptic transmission and long-term memory formation in Drosophila.

Authors:  Hong Zhao; Xingguo Zheng; Xiaojing Yuan; Lei Wang; Xin Wang; Yi Zhong; Zuoping Xie; Tim Tully
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

Review 9.  Translational control of long-lasting synaptic plasticity and memory.

Authors:  Mauro Costa-Mattioli; Wayne S Sossin; Eric Klann; Nahum Sonenberg
Journal:  Neuron       Date:  2009-01-15       Impact factor: 17.173

Review 10.  Fragile X: a family of disorders.

Authors:  Weerasak Chonchaiya; Andrea Schneider; Randi J Hagerman
Journal:  Adv Pediatr       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.